ALFA News
Straight from the exchange filing
Latest Pharmaceuticals stock news from NSE and BSE filings, 95 stories so far.
Cohance Lifesciences receives MCA approval for Umang Vohra as Chairman and Group CEO. Leadership transition follows a Q1 revenue of ₹422.26 Cr and net loss.
Wanbury Limited enters paediatric dermatology with the launch of berrysoft baby products across India. Latest quarterly revenue reached ₹165.58 crore in June 2026.
Lupin Ltd receives U.S. FDA approval for Phytonadione Injectable Emulsion USP, targeting a $52.3 million annual market for vitamin K deficiency treatments.
Evonile Pharma Limited, formerly Novartis India, approves raising up to ₹900 crore via a rights issue of partly paid-up equity shares to eligible shareholders.
Lupin Ltd launches Formoflo-G MDI, the world's first fixed-dose triple combination inhaler for COPD in India, addressing a market of over 55 million patients.
Glenmark Pharmaceuticals launches Adapalene Gel USP 0.1% OTC pump packs in the US, targeting a $45.8M market while reporting a 930% YoY jump in quarterly profit.
Jeena Sikho Lifecare Limited (JSLL) launches 8 new Ayurvedic and nutraceutical products including Jod Xpert and plant proteins to strengthen its domestic portfolio.
Sat Kartar Life Limited board approves raising ₹9.46 crore through 5,50,000 convertible warrants at ₹172 each to promoters for healthcare platform expansion.
Bharat Parenterals Ltd approves raising ₹139 crore through a preferential issue of 9.12 lakh shares to 15 investors, including WhiteOak Capital, for subsidiary growth.
Quest Laboratories Limited enters a strategic advisory collaboration with Niraga Capitals to drive international growth, institutional sales, and capital planning.
Lupin Ltd secured tentative US FDA approval for Apixaban Oral Suspension 1.25mg/mL. The product will be manufactured at Lupin's Somerset, New Jersey facility.
Sun Pharma partners with LIB Therapeutics for global licensing of Lerodalcibep, targeting a US$3.7 billion PCSK9 inhibitor market excluding the US and China.
Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India via the open market, raising her stake to 12.51%. Read more on this transaction here.
NGL Fine-Chem fully commissions its Greenfield facility at Tarapur, starting Phase II commercial production with a total project investment of ₹222 crore.
IOL Chemicals & Pharmaceuticals (IOLCP) receives EU-REACH registration for Triacetin, enabling exports to the EU. Company reports TTM revenue of ₹2,523.63 Cr.
Sanjivani Paranteral Ltd clarifies utilization of ₹5.80 Cr from its 5 lakh warrant issue for machinery and subsidiary working capital to drive future growth.
Kerala Ayurveda Ltd revises its preferential share issue to 6,55,000 shares at ₹190.37 each to Katra Holding to adjust ₹12.47 crore in existing unsecured debt.
Jeena Sikho Lifecare (JSLL) launches Amrit Tattava Vati and Oja Amrit Vati tablets for the domestic market, supporting its ₹851.48 Cr TTM revenue growth strategy.
Dr. Reddy's partners with Takeda to distribute Qdenga, India's first approved dengue vaccine. Availability expected in H1 2027 for the private market.
Alkem Laboratories launches NeuCeno (cenobamate) for partial-onset seizures in India, targeting 9.4 million patients with a once-daily anti-seizure medication.
